Home > Healthcare > Medical Devices > Diagnostic Devices > Zika Virus Testing Market

Zika Virus Testing Market Share

Report ID: GMI5926
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Zika Virus Testing Market Share

Some of the notable key industry players operating in the zika virus testing market include:

Abbott Laboratories
Altona Diagnostics GmbH
ChemBio Diagnostics Inc
ELITechGroup F
Hoffmann-La Roche Ltd
Genekam
DiaSorin (Luminex Corporation)
Novacyt Group
Quest Diagnostics
Siemens Healthcare GmbH
LGC Limited (SeraCare Life Sciences)
Co-Diagnostics Inc
Mediven (Medical Innovation Ventures)
Biocan Diagnostics Inc.
Euroimmun

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for zika virus testing was valued at over USD 174 million in 2022 and will reach more than USD 366 million by 2032, owing to substantial infection awareness, along with growing preference for point of care testing for zika virus for precise detection and effective patient management.

The molecular tests segment will witness CAGR of 7.8% by 2032, backed by the ontinuous technological advancements in molecular diagnostics.

The U.S. zika virus testing market accounted for over USD 40 million in 2022 and is anticipated to witness substantial growth through 2032, on account of growing awareness and concern regarding the impact of zika virus on public health.

Abbott Laboratories, Altona Diagnostics GmbH, ChemBio Diagnostics, Inc., ELITechGroup, F. Hoffmann-La Roche Ltd., LGC Limited (SeraCare Life Sciences), Co-Diagnostics, Inc., Mediven (Medical Innovation Ventures), Biocan Diagnostics, Inc. and Euroimmun among others.